Buscar resultados de ensayos clínicos
Carcinoma, Neuroendocrine - 25 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients Condición: Neuroendocrine Carcinomas Fecha: 2015-05-04 Intervenciones: Drug: TLC 388 40 mg/m2 of TLC 388, given as a 30 (+3) minute intravenous infusion, on Days 1, 8 and 15 o |
Recruiting |
Nombre del estudio: Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3) Condición: Neuroendocrine Carcinoma Fecha: 2014-07-24 Intervenciones: Drug: Everolimus , temozolomide |
Not yet recruiting |
Nombre del estudio: Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma Condición: Pulmonary Large Cell Neuroendocrine Carcinoma Fecha: 2016-10-22 Intervenciones:
|
Completed |
Nombre del estudio: Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma Condición: Neuroendocrine Carcinoma Fecha: 2008-01-22 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer Condición: Neuroendocrine Carcinomas Fecha: 2016-06-29 Intervenciones:
|
Recruiting |
Nombre del estudio: A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas Condición: Gastrointestinal Neuroendocrine Carcinomas Fecha: 2014-08-07 Intervenciones:
|
Completed |
Nombre del estudio: Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract Condición:
Fecha: 2006-07-13 Intervenciones:
|
Completed |
Nombre del estudio: Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma Condición: Neuroendocrine Carcinoma Fecha: 2008-04-18 Intervenciones: Drug: Atiprimod Oral, 14 days on / 14 days off; 30mg capsules |
Completed |
Nombre del estudio: Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma Condición: Neuroendocrine Carcinoma Fecha: 2006-10-11 Intervenciones: Drug: Atiprimod oral, 14 days on / 14 days off; 30mg capsules |
Completed |
Nombre del estudio: Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma Condición: Neuroendocrine Carcinoma Fecha: 2005-09-12 Intervenciones:
|